Automatic quantification of the myocardial extracellular volume by cardiac computed tomography: Synthetic ECV by CCT

Journal of Cardiovascular Computed Tomography

Volumn 11, Issue 3, 2017, Pages 221-226

  Treibel, Thomas A ^a,b   Fontana, Marianna ^a,b   Steeden, Jennifer A ^b   Nasis, Arthur ^a   Yeung, Jason ^b   White, Steven K ^a,b   Sivarajan, Sri ^b   Punwani, Shonit ^b   Pugliese, Francesca ^a   Taylor, Stuart A ^b   Moon, James C ^a,b   Bandula, Steve ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiac amyloidosis; Computed tomography; Extracellular matrix; Myocardial extracellular volume fraction; Myocardial fibrosis; Myocardial tissue characterization

Indexed keywords

IOHEXOL;

ADULT; AMYLOIDOSIS; AORTIC STENOSIS; ARTICLE; CARDIAC IMAGING; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EXTRACELLULAR SPACE; FEMALE; HEART AMYLOIDOSIS; HEMATOCRIT; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; PRIORITY JOURNAL; RETROSPECTIVE STUDY; AUTOMATION; BLOOD; CARDIAC MUSCLE; CARDIOMYOPATHY; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; FIBROSIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBSERVER VARIATION; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; REGRESSION ANALYSIS; REPRODUCIBILITY;

AMYLOIDOSIS; AUTOMATION; CARDIOMYOPATHIES; FIBROSIS; HEMATOCRIT; HUMANS; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYOCARDIUM; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 85014177594     PISSN: 19345925     EISSN: 1876861X     Source Type: Journal    
DOI: 10.1016/j.jcct.2017.02.006     Document Type: Article

References (29)

1. 1 Bandula, S., White, S.K., Flett, A.S., et al. Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced CT: validation against histologic findings. Radiology 269 (2013), 396–403.
2. 2 Nacif, M.S., Kawel, N., Lee, J.J., et al. Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT. Radiology 264 (2012), 876–883.
3. 3 Nacif, M.S., Liu, Y., Yao, J., et al. 3D left ventricular extracellular volume fraction by low-radiation dose cardiac CT: assessment of interstitial myocardial fibrosis. J Cardiovasc Comput Tomogr 7 (2013), 51–57.
4. 4 Treibel, T.A., Bandula, S., Fontana, M., et al. Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis. J Cardiovasc Comput Tomogr 9:6 (2015 Nov-Dec), 585–592.
5. 5 Kurita, Y., Kitagawa, K., Kurobe, Y., et al. Estimation of myocardial extracellular volume fraction with cardiac CT in subjects without clinical coronary artery disease: a feasibility study. J Cardiovasc Comput Tomogr 10 (2016), 237–241.
6. 6 Ugander, M., Oki, A.J., Hsu, L.Y., et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 33 (2012), 1268–1278.
7. 7 Banypersad, S.M., Fontana, M., Maestrini, V., et al. T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J 36 (2015), 244–251.
8. 8 Wong, T.C., Piehler, K., Meier, C.G., et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 126 (2012), 1206–1216.
9. 9 Wong, T.C., Piehler, K.M., Kang, I.A., et al. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J 35 (2014), 657–664.
10. 10 Schelbert, E.B., Fonarow, G.C., Bonow, R.O., Butler, J., Gheorghiade, M., Therapeutic targets in heart failure: refocusing on the myocardial interstitium. J Am Coll Cardiol 63 (2014), 2188–2198.
11. 11 Moon, J.C., Treibel, T.A., Schelbert, E.B., T1 mapping for diffuse myocardial fibrosis: a key biomarker in cardiac disease?. J Am Coll Cardiol 62 (2013), 1288–1289.
12. 12 New, P.F., Aronow, S., Attenuation measurements of whole blood and blood fractions in computed tomography. Radiology 121 (1976), 635–640.
13. 13 Black, D.F., Rad, A.E., Gray, L.A., Campeau, N.G., Kallmes, D.F., Cerebral venous sinus density on noncontrast CT correlates with hematocrit. AJNR Am J Neuroradiol 32 (2011), 1354–1357.
14. 14 Collins, A.J., Gillespie, S., Kelly, B.E., Can computed tomography identify patients with anaemia?. Ulster Med J 70 (2001), 116–118.
15. 15 Lan, H., Nishihara, S., Nishitani, H., Accuracy of computed tomography attenuation measurements for diagnosing anemia. Jpn J Radiol 28 (2010), 53–57.
16. 16 Jung, C., Groth, M., Bley, T.A., et al. Assessment of anemia during CT pulmonary angiography. Eur J Radiol 81 (2012), 4196–4202.
17. 17 Kamel, E.M., Rizzo, E., Duchosal, M.A., et al. Radiological profile of anemia on unenhanced MDCT of the thorax. Eur Radiol 18 (2008), 1863–1868.
18. 18 Wojtowicz, J., Rzymski, K., Czarnecki, R., Severe anaemia: its CT findings in the cardiovascular system. Eur J Radiol 3 (1983), 108–111.
19. 19 Doppman, J.L., Rienmuller, R., Lissner, J., The visualized interventricular septum on cardiac computed tomography: a clue to the presence of severe anemia. J Comput assisted Tomogr 5 (1981), 157–160.
20. 20 Jalbert, F., Paoli, J.R., Osirix: free and open-source software for medical imagery. Revue de stomatologie de Chir maxillo-faciale 109 (2008), 53–55.
21. 21 Flett, A.S., Flett, A.S., Hayward, M.P., et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122 (2010), 138–144.
22. 22 Rosmini, S., Treibel, T.A., Bandula, S., et al. Cardiac computed tomography for the detection of cardiac amyloidosis. J Cardiovasc Comput Tomogr, 2016.
23. 23 Moon, J.C., Messroghli, D.R., Kellman, P., et al. Myocardial T1 mapping and extracellular volume quantification: a society for cardiovascular magnetic resonance (SCMR) and CMR working group of the European society of cardiology consensus statement. J Cardiovasc Magn Reson, 15, 2013, 92.
24. 24 Coelho-Filho, O.R., Holland, D.J., Mongeon, F.P., et al. Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Circ Cardiovasc imaging 6 (2013), 134–141.
25. 25 Banypersad, S.M., Banypersad, S.M., Sado, D.M., et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc imaging 6 (2013), 34–39.
26. 26 Wong, T.C., Wong, T.C., Piehler, K.M., et al. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J, 2013.
27. 27 Thirup, P., Haematocrit: within-subject and seasonal variation. Sports Med 33 (2003), 231–243.
28. 28 Bydder, G.M., Kreel, L., The temperature dependence of computed tomography attenuation values. J Comput assisted Tomogr 3 (1979), 506–510.
29. 29 Nacif, M.S., Liu, Y., Yao, J., et al. 3D left ventricular extracellular volume fraction by low-radiation dose cardiac CT: assessment of interstitial myocardial fibrosis. J Cardiovasc Comput Tomogr 7 (2013), 51–57.